RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges

RadNet (RDNT) delivered a substantial earnings beat in Q2 2026 with total company revenue climbing 25.0% year-over-year to $622.7 million, establishing a new quarterly record. Adjusted EBITDA expanded 22.7% to $99.7 million, demonstrating improved operational leverage despite rapid top-line growth. The Digital Health segment proved particularly compelling, with revenue surging 56.5% to $32.4 million—a critical indicator of software-as-service scaling within the healthcare vertical.

The upward revision of 2026 full-year guidance signals management confidence in sustained momentum. Annual Recurring Revenue (ARR) nearly doubled from $53.5 million (June 2025) to $105.5 million (June 2026), highlighting strong subscription durability and recurring revenue transition. This metric is material for investors evaluating long-term visibility and reducing cyclicality exposure in healthcare services.

The earnings surprise and guidance raise represent a thesis-change catalyst for RDNT, justifying upgrading investment conviction on execution against digital transformation tailwinds within radiology and diagnostic imaging networks. Margin expansion coupled with accelerating ARR demonstrates both unit economics and business model resilience are strengthening.

Sector implication: Healthcare technology subsector benefits from secular demand for workflow automation and telehealth integration. RDNT's results validate digital health adoption acceleration, potentially benefiting adjacent diagnostic software and healthcare IT vendors competing in modernization cycles.